Form 8-K - Current report:
SEC Accession No. 0001193125-24-281283
Filing Date
2024-12-18
Accepted
2024-12-18 16:06:01
Documents
17
Period of Report
2024-12-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d895886d8k.htm   iXBRL 8-K 37946
2 EX-10.1 d895886dex101.htm EX-10.1 20458
3 EX-10.2 d895886dex102.htm EX-10.2 4074
8 GRAPHIC g895886g1217081624543.jpg GRAPHIC 3203
  Complete submission text file 0001193125-24-281283.txt   237985

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA dbvt-20241216.xsd EX-101.SCH 3101
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dbvt-20241216_def.xml EX-101.DEF 13867
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbvt-20241216_lab.xml EX-101.LAB 22898
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbvt-20241216_pre.xml EX-101.PRE 14705
19 EXTRACTED XBRL INSTANCE DOCUMENT d895886d8k_htm.xml XML 5898
Mailing Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320
Business Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36697 | Film No.: 241559210
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)